Key result
Pulmonary hypertension (present in 43.8% of patients) and right ventricular dysfunction (42.2%) had a compounding detrimental effect on 3-year mortality in patients with heart failure.
Why the study?
Does the presence of pulmonary hypertension and right ventricular dysfunction predict all-cause mortality in patients with heart failure?
Cohort (n=306)
Does the presence of pulmonary hypertension and right ventricular dysfunction predict all-cause mortality in patients with heart failure?
The combination of pulmonary hypertension and right ventricular dysfunction significantly worsens prognosis in heart failure, while RV dysfunction without PH does not increase 3-year mortality.
Answers are grounded in this paper and cite their sources.
Highlights combined right ventricular and pulmonary assessment for risk stratification in heart failure; leaves open.
Objective: Pulmonary hypertension (PH) is one of the fundamental echocardiography parameters of prognostic importance in heart failure (HF) diseases. Recently, right ventricular (RV) function is being increasingly recognized as critical parameter in terms of mortality outcomes both in acute and chronic HF. We sought to determine the prognostic significance of PH and RV function in patients of acute and chronic HF from retrospective institutional data. Methodology: We studied 306 patients with HF presentation including acute decompensated HF. Pulmonary artery systolic pressure (PASP) and RV function were determined with the use of Doppler echocardiography, with PH as PASP >50 mmHg and tricuspid annular plane systolic excursion (TAPSE) <1.6 cm along with global RV fractional area change. The primary endpoint was all-cause mortality during 3-year follow-up. Results: PH was present in 134 patients (43.8%) and RV dysfunction in 129 patients (42.2%). The majority of patients with RV dysfunction had PH (58.1%). Patients with normal RV function and PH had an intermediate risk. However, patients with RV dysfunction without PH were not at increased risk for 3-year mortality. Conclusion: Critical echocardiography parameters in the evaluation of HF include PASP for pressure and volume overload status as well as RV function. The incremental prognosis is also determined by PH and RV function. The compounding effect of PH & RV dysfunction is detrimental in terms of high morbidity rates and mortality outcomes.
No takes yet. Share an insight, caveat, or question.
Vora et al. (2018) conducted a cohort in Heart failure (n=306). Pulmonary hypertension and right ventricular dysfunction vs. Absence of pulmonary hypertension and right ventricular dysfunction was evaluated on All-cause mortality. Pulmonary hypertension (present in 43.8% of patients) and right ventricular dysfunction (42.2%) had a compounding detrimental effect on 3-year mortality in patients with heart failure.
Synapse has enriched 10 related papers. Consider them for comparative context: